LEVETIRACETAM DEXCEL 500

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

LEVETIRACETAM

Dostupno od:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC koda:

N03AX14

Farmaceutski oblik:

TABLETS

Sastav:

LEVETIRACETAM 500 MG

Administracija rute:

PER OS

Tip recepta:

Required

Proizveden od:

DEXCEL LTD, ISRAEL

Terapijska grupa:

LEVETIRACETAM

Područje terapije:

LEVETIRACETAM

Terapijske indikacije:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Datum autorizacije:

2018-03-31